Erratum: An ex vivo model to induce early fibrosis-like changes in human precision-cut lung slices (American Journal of Physiology - Lung Cellular and Molecular Physiology (2017) 312 (L896-L902) DOI: 10.1152/ajplung.00084.2017);An ex vivo model to induce early fibrosis-like changes in human precision-cut lung slices

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 312, Issue 6, 2017, Pages L896-L902

  Alsafadi, Hani N ^a   Staab Weijnitz, Claudia A ^a   Lehmann, Mareike ^a   Lindner, Michael ^b   Peschel, Britta ^a   Königshoff, Melanie ^a,c   Wagner, Darcy E ^a  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b ASKLEPIOS FACHKLINIKEN MÜNCHEN GAUTING   (Germany)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Disease model; Ex vivo; Fibrosis; Idiopathic pulmonary fibrosis; Precision cut lung slices

Indexed keywords

GROWTH FACTOR; LYSOPHOSPHATIDIC ACID; PLATELET DERIVED GROWTH FACTOR AB; SURFACTANT PROTEIN C; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR; AUTACOID; BIOLOGICAL MARKER; COLLAGEN TYPE 1;

ARTICLE; CELL REPROGRAMMING TECHNIQUE; ENZYME LINKED IMMUNOSORBENT ASSAY; EX VIVO STUDY; FIBROSING ALVEOLITIS; GENE EXPRESSION; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; LUNG ALVEOLUS EPITHELIUM CELL; LUNG SLICE; PRECISION CUT LUNG SLICE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; WST-1 ASSAY; AGED; BIOLOGICAL MODEL; EXTRACELLULAR MATRIX; FEMALE; LUNG; MALE; METABOLISM; PATHOLOGY; TISSUE SURVIVAL; UPREGULATION;

AGED; ALVEOLAR EPITHELIAL CELLS; BIOMARKERS; COLLAGEN TYPE I; EXTRACELLULAR MATRIX; FEMALE; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; INFLAMMATION MEDIATORS; LUNG; MALE; MODELS, BIOLOGICAL; TISSUE SURVIVAL; UP-REGULATION;

EID: 85020229711     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/AJPLUNG.ZH5-7811-CORR.2020     Document Type: Erratum

References (21)

1. Agostini C, Gurrieri C. Chemokine/cytokine cocktail in idiopathic pulmonary fibrosis. Proc Am Thorac Soc 3: 357–363, 2006. doi: 10.1513/pats. 200601-010TK.
2. Arora PD, Narani N, McCulloch CA. The compliance of collagen gels regulates transforming growth factor-beta induction of alpha-smooth muscle actin in fibroblasts. Am J Pathol 154: 871–882, 1999. doi: 10.1016/ S0002-9440 (10) 65334-5.
3. Aumiller V, Balsara N, Wilhelm J, Günther A, Königshoff M. WNT/ +-catenin signaling induces IL-1+ expression by alveolar epithelial cells in pulmonary fibrosis. Am J Respir Cell Mol Biol 49: 96–104, 2013. doi: 10. 1165/rcmb.2012-0524OC.
4. Booth AJ, Hadley R, Cornett AM, Dreffs AA, Matthes SA, Tsui JL, Weiss K, Horowitz JC, Fiore VF, Barker TH, Moore BB, Martinez FJ, Niklason LE, White ES. Acellular normal and fibrotic human lung matrices as a culture system for in vitro investigation. Am J Respir Crit Care Med 186: 866–876, 2012. doi: 10.1164/rccm.201204-0754OC.
5. Georges PC, Hui JJ, Gombos Z, McCormick ME, Wang AY, Uemura M, Mick R, Janmey PA, Furth EE, Wells RG. Increased stiffness of the rat liver precedes matrix deposition: implications for fibrosis. Am J Physiol Gastrointest Liver Physiol 293: G1147–G1154, 2007. doi: 10.1152/ajpgi. 00032.2007.
6. Jain R, Barkauskas CE, Takeda N, Bowie EJ, Aghajanian H, Wang Q, Padmanabhan A, Manderfield LJ, Gupta M, Li D, Li L, Trivedi CM, Hogan BL, Epstein JA. Plasticity of Hopx (+) type I alveolar cells to regenerate type II cells in the lung. Nat Commun 6: 6727, 2015. doi: 10. 1038/ncomms7727.
7. King TE Jr, Pardo A, Selman M. Idiopathic pulmonary fibrosis. Lancet 378: 1949–1961, 2011. doi: 10.1016/S0140-6736 (11) 60052-4.
8. Lauenstein L, Switalla S, Prenzler F, Seehase S, Pfennig O, Förster C, Fieguth H, Braun A, Sewald K. Assessment of immunotoxicity induced by chemicals in human precision-cut lung slices (PCLS). Toxicol In Vitro 28: 588–599, 2014. doi: 10.1016/j.tiv.2013.12.016.
9. Marinkovic A, Mih JD, Park JA, Liu F, Tschumperlin DJ. Improved throughput traction microscopy reveals pivotal role for matrix stiffness in fibroblast contractility and TGF-+ responsiveness. Am J Physiol Lung Cell Mol Physiol 303: L169–L180, 2012. doi: 10.1152/ajplung.00108.2012.
10. Martin C, Uhlig S, Ullrich V. Cytokine-induced bronchoconstriction in precision-cut lung slices is dependent upon cyclooxygenase-2 and thromboxane receptor activation. Am J Respir Cell Mol Biol 24: 139–145, 2001. doi: 10.1165/ajrcmb.24.2.3545.
11. Mercer PF, Woodcock HV, Eley JD, Platé M, Sulikowski MG, Durrenberger PF, Franklin L, Nanthakumar CB, Man Y, Genovese F, McAnulty RJ, Yang S, Maher TM, Nicholson AG, Blanchard AD, Marshall RP, Lukey PT, Chambers RC. Exploration of a potent PI3 kinase/mTOR inhibitor as a novel anti-fibrotic agent in IPF. Thorax 71: 701–711, 2016. doi: 10.1136/thoraxjnl-2015-207429.
12. Moore BB, Hogaboam CM. Murine models of pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 294: L152–L160, 2008. doi: 10.1152/ ajplung.00313.2007.
13. Raghu G, Selman M. Nintedanib and pirfenidone. New antifibrotic treatments indicated for idiopathic pulmonary fibrosis offer hopes and raises questions. Am J Respir Crit Care Med 191: 252–254, 2015. doi: 10.1164/rccm.201411-2044ED.
14. Rydell-Törmänen K, Zhou XH, Hallgren O, Einarsson J, Eriksson L, Andersson-Sjöland A, Westergren-Thorsson G. Aberrant nonfibrotic parenchyma in idiopathic pulmonary fibrosis is correlated with decreased +-catenin inhibition and increased Wnt5a/b interaction. Physiol Rep 4: e12727, 2016. doi: 10.14814/phy2.12727.
15. Selman M, Pardo A. Role of epithelial cells in idiopathic pulmonary fibrosis: from innocent targets to serial killers. Proc Am Thorac Soc 3: 364–372, 2006. doi: 10.1513/pats.200601-003TK.
16. Tatler AL, Barnes J, Habgood A, Goodwin A, McAnulty RJ, Jenkins G. Caffeine inhibits TGF+ activation in epithelial cells, interrupts fibroblast responses to TGF+, and reduces established fibrosis in ex vivo precision-cut lung slices. Thorax 71: 565–567, 2016. doi: 10.1136/ thoraxjnl-2015-208215.
17. Uhl FE, Vierkotten S, Wagner DE, Burgstaller G, Costa R, Koch I, Lindner M, Meiners S, Eickelberg O, Königshoff M. Preclinical validation and imaging of Wnt-induced repair in human 3D lung tissue cultures. Eur Respir J 46: 1150–1166, 2015. doi: 10.1183/09031936. 00183214.
18. Vuga LJ, Ben-Yehudah A, Kovkarova-Naumovski E, Oriss T, Gibson KF, Feghali-Bostwick C, Kaminski N. WNT5A is a regulator of fibroblast proliferation and resistance to apoptosis. Am J Respir Cell Mol Biol 41: 583–589, 2009. doi: 10.1165/rcmb.2008-0201OC.
19. Wagner DE, Bonenfant NR, Sokocevic D, DeSarno MJ, Borg ZD, Parsons CS, Brooks EM, Platz JJ, Khalpey ZI, Hoganson DM, Deng B, Lam YW, Oldinski RA, Ashikaga T, Weiss DJ. Three-dimensional scaffolds of acellular human and porcine lungs for high throughput studies of lung disease and regeneration. Biomaterials 35: 2664–2679, 2014. doi: 10.1016/j.biomaterials.2013.11.078.
20. White ES, Xia M, Murray S, Dyal R, Flaherty CM, Flaherty KR, Moore BB, Cheng L, Doyle TJ, Villalba J, Dellaripa PF, Rosas IO, Kurtis JD, Martinez FJ. Plasma surfactant protein-D, matrix metalloproteinase-7, and osteopontin index distinguishes idiopathic pulmonary fibrosis from other idiopathic interstitial pneumonias. Am J Respir Crit Care Med 194: 1242–1251, 2016. doi: 10.1164/rccm.201505-0862OC.
21. Xu Y, Mizuno T, Sridharan A, Du Y, Guo M, Tang J, Wikenheiser-Brokamp KA, Perl AT, Funari VA, Gokey JJ, Stripp BR, Whitsett JA. Single-cell RNA sequencing identifies diverse roles of epithelial cells in idiopathic pulmonary fibrosis. JCI Insight 1: e90558, 2016. doi: 10. 1172/jci.insight.90558.